Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study

BACKGROUND: Paraneoplastic syndromes (PNS) are autoimmune disorders specifically associated with cancer. There are few data on anti-PD-1 or anti-PD-L1 immunotherapy in patients with a PNS. Our objective was to describe the outcome for patients with a pre-existing or newly diagnosed PNS following the...

Descripción completa

Detalles Bibliográficos
Autores principales: Manson, Guillaume, Maria, Alexandre Thibault Jacques, Poizeau, Florence, Danlos, François-Xavier, Kostine, Marie, Brosseau, Solenn, Aspeslagh, Sandrine, Du Rusquec, Pauline, Roger, Maxime, Pallix-Guyot, Maud, Ruivard, Marc, Dousset, Léa, Grignou, Laurianne, Psimaras, Dimitri, Pluvy, Johan, Quéré, Gilles, Grados, Franck, Duval, Fanny, Bourdain, Frederic, Maigne, Gwenola, Perrin, Julie, Godbert, Benoit, Taifas, Beatris Irina, Forestier, Alexandra, Voisin, Anne-Laure, Martin-Romano, Patricia, Baldini, Capucine, Marabelle, Aurélien, Massard, Christophe, Honnorat, Jérôme, Lambotte, Olivier, Michot, Jean-Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892018/
https://www.ncbi.nlm.nih.gov/pubmed/31796119
http://dx.doi.org/10.1186/s40425-019-0821-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892018/
https://www.ncbi.nlm.nih.gov/pubmed/31796119
http://dx.doi.org/10.1186/s40425-019-0821-8

Ejemplares similares